 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| BAT8010 - Bio / Thera Solutions
New P1 trial, Metastases: Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients (clinicaltrials.gov) - May 8, 2023
P1, N=109, Recruiting, Sponsor: Bio-Thera Solutions